RR

Rimjhim Rani

Active Director Director DIN 09125713
DIN 09125713 First appointment Mar 2021 Primary industry Construction
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Rimjhim Rani

Data last updated:

Rimjhim Rani is a Director at Medicrit Biopharma Private Limited (since 2021). The company operates in Construction. Medicrit Biopharma Private Limited reported revenue of ₹4.77 Cr (FY 2025).

DIN 09125713
Primary Designation Director
Industry Construction
First Appointment 26 Mar 2021
Oldest Company Age 5 yrs
Largest company Medicrit Biopharma Private Limited · ₹4.77 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicrit Biopharma Private Limited U45309MH2021PTC358008
Director26 Mar 20212021₹4.77 Cr (FY 2025)Active

Board colleagues of Rimjhim Rani

NameDINCompanyDesignation
Priyanka Kumari09125702Medicrit Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medicrit Biopharma Private Limited
Premium access

Shareholding and investment profile for Rimjhim Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rimjhim Rani

Rimjhim Rani currently holds 1 directorship: Medicrit Biopharma Private Limited (Director, since 26 Mar 2021, revenue ₹4.77 Cr (FY 2025)).

Rimjhim Rani was first appointed on 26 Mar 2021 as Director at Medicrit Biopharma Private Limited.

The current boards of Rimjhim Rani's companies include Priyanka Kumari (Medicrit Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available